Mico BioMed Co. Ltd. (214610) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.315x

Based on the latest financial reports, Mico BioMed Co. Ltd. (214610) has a cash flow conversion efficiency ratio of -0.315x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-8.13 Billion ≈ $-5.51 Million USD) by net assets (₩25.81 Billion ≈ $17.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Mico BioMed Co. Ltd. liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Mico BioMed Co. Ltd. - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Mico BioMed Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mico BioMed Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mico BioMed Co. Ltd. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Moleculin Biotech Inc NASDAQ:MBRX	-0.358x
Prochem S.A. WAR:PRM	0.020x
SSR Inc KQ:275630	0.043x
Way 2 Vat Ltd AU:W2V	-1.805x
Aurora Spine Corp V:ASG	-0.004x
Wooree Lighting Co.Ltd KQ:037400	-0.060x
OSR Holdings Inc NASDAQ:OSRH	-0.008x
Bd Multimedia PA:ALBDM	0.061x

Annual Cash Flow Conversion Efficiency for Mico BioMed Co. Ltd. (2016–2024)

The table below shows the annual cash flow conversion efficiency of Mico BioMed Co. Ltd. from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Mico BioMed Co. Ltd. (214610) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩25.89 Billion ≈ $17.54 Million	₩-10.70 Billion ≈ $-7.25 Million	-0.413x	-32.16%
2023-12-31	₩36.33 Billion ≈ $24.62 Million	₩-11.36 Billion ≈ $-7.70 Million	-0.313x	+60.50%
2022-12-31	₩17.69 Billion ≈ $11.99 Million	₩-14.01 Billion ≈ $-9.49 Million	-0.792x	-381.03%
2021-12-31	₩52.26 Billion ≈ $35.42 Million	₩-8.60 Billion ≈ $-5.83 Million	-0.165x	+50.70%
2020-12-31	₩55.96 Billion ≈ $37.92 Million	₩-18.68 Billion ≈ $-12.66 Million	-0.334x	+96.73%
2019-12-31	₩1.02 Billion ≈ $691.72K	₩-10.43 Billion ≈ $-7.07 Million	-10.223x	-759.39%
2018-12-31	₩5.71 Billion ≈ $3.87 Million	₩-6.79 Billion ≈ $-4.60 Million	-1.190x	-40.61%
2017-12-31	₩3.42 Billion ≈ $2.32 Million	₩-2.89 Billion ≈ $-1.96 Million	-0.846x	+18.99%
2016-12-31	₩3.83 Billion ≈ $2.59 Million	₩-3.99 Billion ≈ $-2.71 Million	-1.044x	--

About Mico BioMed Co. Ltd.

KQ:214610 Korea Publishing

Market Cap

$13.00 Million

₩19.18 Billion KRW

Market Cap Rank

#26390 Global

#1939 in Korea

Share Price

₩2290.00

Change (1 day)

-2.35%

52-Week Range

₩2255.00 - ₩6250.00

All Time High

₩12100.26